ALLMedicine™ Hidradenitis Suppurativa Center
Research & Reviews 1,506 results
https://doi.org/10.1007/s40257-022-00711-1
American Journal of Clinical Dermatology; Shih T, De D et. al.
Aug 6th, 2022 - Hidradenitis suppurativa (HS) is a chronic, progressive inflammatory skin disease that is often recalcitrant to multiple treatments. In determining biologic candidacy for patients with HS, we propose a paradigm shift away from Hurley staging and t...
https://clinicaltrials.gov/ct2/show/NCT04988308
Aug 4th, 2022 - Hidradenitis suppurativa (HS) is a chronic skin disease of unclear etiology that affects 1 percent (%) to 4% of the general population. JNJ-77474462 (bermekimab) is a recombinant human immunoglobulin G1 kappa (IgG1k) monoclonal antibody (mAb) that...
https://doi.org/10.1111/jdv.18473
Journal of the European Academy of Dermatology and Venere... Radhakrishna U, Uppala R et. al.
Aug 4th, 2022 - Hidradenitis suppurativa (HS) is a chronic inflammatory disease influenced by genetics, non-genetic, and environmental factors that modulate miRNA expression. Currently, no miRNA data are available for HS. In this study, we profiled DNA methylatio...
https://clinicaltrials.gov/ct2/show/NCT05384249
Aug 4th, 2022 - Izokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin-17A, to which it binds with high affinity. Izokibep has been investigated in non-clinical and clinical studies including healthy subjects and patients w...
https://clinicaltrials.gov/ct2/show/NCT04242446
Aug 3rd, 2022 - The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)
Guidelines 1 results
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.
Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...
Drugs 1 results see all →
Clinicaltrials.gov 138 results
https://clinicaltrials.gov/ct2/show/NCT04988308
Aug 4th, 2022 - Hidradenitis suppurativa (HS) is a chronic skin disease of unclear etiology that affects 1 percent (%) to 4% of the general population. JNJ-77474462 (bermekimab) is a recombinant human immunoglobulin G1 kappa (IgG1k) monoclonal antibody (mAb) that...
https://clinicaltrials.gov/ct2/show/NCT05384249
Aug 4th, 2022 - Izokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin-17A, to which it binds with high affinity. Izokibep has been investigated in non-clinical and clinical studies including healthy subjects and patients w...
https://clinicaltrials.gov/ct2/show/NCT04242446
Aug 3rd, 2022 - The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)
https://clinicaltrials.gov/ct2/show/NCT05139602
Aug 2nd, 2022 - Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under armpits, inner thighs, groin and buttocks. Despit...
https://clinicaltrials.gov/ct2/show/NCT05484674
Aug 2nd, 2022 - Hidradenitis Suppurativa (HS) is a chronic inflammatory disorder characterized by follicular occlusion and rupture which leads to scar and sinus tract formation. Given that medical treatments for HS primarily target inflammation, a multifaceted ap...
News 249 results
https://www.mdedge.com/dermatology/article/256280/pediatrics/study-eyes-characteristics-pediatric-patients-hidradenitis
Doug Brunk
Jul 14th, 2022 - INDIANAPOLIS – Nearly two-thirds of pediatric patients with hidradenitis suppurativa (HS) met criteria for obesity at the time of their diagnosis, and 36% had acne, in a study presented at the annual meeting of the Society for Pediatric Dermatolog.
https://www.medscape.com/viewarticle/977227
Jul 14th, 2022 - INDIANAPOLIS — Nearly two-thirds of pediatric patients with hidradenitis suppurativa (HS) met criteria for obesity at the time of their diagnosis, and 36% had acne, in a study presented at the annual meeting of the Society for Pediatric Dermatolog...
https://www.mdedge.com/dermatology/article/256028/acne/can-dietary-tweaks-improve-some-skin-diseases
Kathleen Doheny
Jul 5th, 2022 - Since 1950, the terms “diet and skin” in the medical literature have markedly increased, said Vivian Shi, MD associate professor of dermatology at the University of Arkansas for Medical Sciences, Little Rock, who talked about nutritional approache.
https://www.medscape.com/viewarticle/971955
Apr 11th, 2022 - BOSTON ― The use of carbon dioxide (CO2) laser excision therapy for hidradenitis suppurativa (HS) is not associated with an increased risk for the development of keloids, new research shows. "With keloids disproportionately affecting Black and oth...
https://www.mdedge.com/dermatology/article/253285/hidradenitis-suppurativa/therapeutic-considerations-adults-hidradenitis
Jennifer Hsiao, MD
Apr 1st, 2022 - Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent boils, abscesses, and nodules that can progress to narrow channels that form under the skin. An estimated 1%-4% of the US population has the conditio.